Neoleukin Therapeutics, Inc. (AQXP) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Interest income on investments							0.6	0.1
Total interest income							0.6	0.1
Net interest income							0.6	0.1
Pre-tax income before non-recurring items	-57.6	-60.7	-41.1	-69.4	-31.6	-50.2	-37.0	-21.9
Non-recurring items			-7.8
Pre-tax income	-57.6	-60.7	-33.3	-69.4	-31.6	-50.2	-37.0	-21.9
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-57.6	-60.7	-33.3	-69.4	-31.6	-50.2	-37.0	-21.9
Net margin			-44.2%	-73.7%	-126.3%	-138.4%	-6167.0%	-21860.0%

Basic EPS	($1.04)	($1.10)	($0.64)	($2.57)	($1.34)	($2.14)	($1.96)	($1.73)
Diluted EPS	($1.04)	($1.10)	($0.64)	($2.57)	($1.34)	($2.14)	($1.96)	($1.73)

Shares outstanding (basic)	55.2	55.0	51.8	27.0	23.5	23.5	18.9	12.6
Shares outstanding (diluted)	55.2	55.0	51.8	27.0	23.5	23.5	18.9	12.6

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.